KC Investment Advisors LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,416 shares of the company’s stock after buying an additional 65 shares during the period. KC Investment Advisors LLC’s holdings in HCA Healthcare were worth $706,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Valley National Advisers Inc. increased its holdings in shares of HCA Healthcare by 37.9% in the second quarter. Valley National Advisers Inc. now owns 171 shares of the company’s stock valued at $35,000 after purchasing an additional 47 shares during the period. MUFG Americas Holdings Corp purchased a new stake in shares of HCA Healthcare in the second quarter valued at approximately $37,000. Eagle Bay Advisors LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at approximately $46,000. Fred Alger Management LLC purchased a new stake in HCA Healthcare during the first quarter worth $47,000. Finally, Penserra Capital Management LLC boosted its position in HCA Healthcare by 18.5% during the first quarter. Penserra Capital Management LLC now owns 665 shares of the company’s stock worth $125,000 after purchasing an additional 104 shares in the last quarter. 68.57% of the stock is currently owned by institutional investors and hedge funds.
A number of analysts have commented on HCA shares. Citigroup boosted their target price on HCA Healthcare from $215.00 to $268.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 21st. Seaport Res Ptn reissued a “buy” rating on shares of HCA Healthcare in a report on Friday, July 9th. Raymond James boosted their price target on HCA Healthcare from $225.00 to $290.00 and gave the stock an “outperform” rating in a report on Wednesday, July 21st. Seaport Global Securities began coverage on HCA Healthcare in a research note on Friday, July 9th. They issued a “buy” rating and a $235.00 target price for the company. They noted that the move was a valuation call. Finally, Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating and set a $218.00 target price for the company. in a research note on Tuesday, June 15th. Five equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $250.09.
HCA Healthcare (NYSE:HCA) last released its earnings results on Monday, July 19th. The company reported $4.37 EPS for the quarter, topping analysts’ consensus estimates of $3.16 by $1.21. HCA Healthcare had a return on equity of 234.29% and a net margin of 8.87%. The company had revenue of $14.44 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter last year, the business posted $3.23 EPS. HCA Healthcare’s quarterly revenue was up 30.4% compared to the same quarter last year. As a group, research analysts forecast that HCA Healthcare, Inc. will post 16.78 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 30th. Stockholders of record on Thursday, September 16th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Wednesday, September 15th. HCA Healthcare’s payout ratio is 16.54%.
In other HCA Healthcare news, insider Charles J. Hall sold 3,000 shares of the stock in a transaction on Tuesday, July 27th. The stock was sold at an average price of $249.94, for a total transaction of $749,820.00. Following the completion of the transaction, the insider now directly owns 210,140 shares of the company’s stock, valued at approximately $52,522,391.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CMO Jonathan B. Perlin sold 40,000 shares of the stock in a transaction on Monday, August 2nd. The shares were sold at an average price of $250.00, for a total value of $10,000,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 59,093 shares of company stock worth $14,778,068 over the last quarter. Insiders own 1.60% of the company’s stock.
HCA Healthcare Profile
HCA Healthcare, Inc is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Featured Article: Does the Step Transaction Doctrine Affect a Backdoor Roth IRA?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.